2024
Rectourethral fistula after perirectal spacer placement requiring pelvic exenteration
Shah Y, Lokeshwar S, Brutus N, Sterling J. Rectourethral fistula after perirectal spacer placement requiring pelvic exenteration. BMJ Case Reports 2024, 17: e263333. PMID: 39719384, DOI: 10.1136/bcr-2024-263333.Peer-Reviewed Original ResearchConceptsPelvic exenterationRectourethral fistulaSpacer placementRectal radiation doseRobotic pelvic exenterationProstate cancer treatmentManagement of complicationsImprove cancer controlRectal toxicityGastrointestinal toxicitySpacer useClinical benefitFecal diversionSevere complicationsPostmarketing dataPatient counselingCancer controlRadiation doseCancer treatmentSevere outcomesLack of evidenceEarly identificationExenterationPhysician techniqueFistulaPOUR-Net: A Population-Prior-Aided Over-Under-Representation Network for Low-Count PET Attenuation Map Generation
Zhou B, Hou J, Chen T, Zhou Y, Chen X, Xie H, Liu Q, Guo X, Xia M, Tsai Y, Panin V, Toyonaga T, Duncan J, Liu C. POUR-Net: A Population-Prior-Aided Over-Under-Representation Network for Low-Count PET Attenuation Map Generation. IEEE Transactions On Medical Imaging 2024, PP: 1-1. PMID: 40030468, DOI: 10.1109/tmi.2024.3514925.Peer-Reviewed Original ResearchPOUR-Net: A Population-Prior-Aided Over-Under-Representation Network for Low-Count PET Attenuation Map Generation
Zhou B, Hou J, Chen T, Zhou Y, Chen X, Xie H, Liu Q, Guo X, Xia M, Tsai Y, Panin V, Toyonaga T, Duncan J, Liu C. POUR-Net: A Population-Prior-Aided Over-Under-Representation Network for Low-Count PET Attenuation Map Generation. 2024, 00: 1-1. DOI: 10.1109/nss/mic/rtsd57108.2024.10658051.Peer-Reviewed Original ResearchPET attenuation correctionLow-dose PETAttenuation correctionU-mapAttenuation mapElevated radiation doseRadiation doseEfficient feature extractionRadiation exposurePET imagingFinely detailed featuresBaseline methodsMitigate radiation exposureFeature extractionCorrectionMap generationGeneration machinesAn Investigation on Cross-Tracer Generalizability of Deep Learning-based PET Attenuation Correction
Hou J, Chen T, Zhou Y, Chen X, Xie H, Liu Q, Xia M, Panin V, Liu C, Zhou B, Toyonaga T. An Investigation on Cross-Tracer Generalizability of Deep Learning-based PET Attenuation Correction. 2024, 00: 1-1. DOI: 10.1109/nss/mic/rtsd57108.2024.10657095.Peer-Reviewed Original ResearchAttenuation correctionPET attenuation correctionQuantitative PET imagingAttenuation mapDL modelsDeep learning (DL)-based methodsTumor quantificationDL model trainingRadiation doseImmediate future workCompetitive performancePET imagingModel trainingPET signalCorrectionAnalysis of PETFuture workPreliminary resultsData availabilityRadiation2.5D Multi-view Averaging Diffusion Model for 3D Medical Image Translation: Application to Low-count PET Reconstruction with CT-less AC
Chen T, Hou J, Xie H, Chen X, Zhou Y, Xia M, Duncan J, Liu C, Zhou B. 2.5D Multi-view Averaging Diffusion Model for 3D Medical Image Translation: Application to Low-count PET Reconstruction with CT-less AC. 2024, 00: 1-2. DOI: 10.1109/nss/mic/rtsd57108.2024.10658551.Peer-Reviewed Original ResearchLow-dose PETStandard-dose PETImage-to-image translationPositron emission tomographyAttenuation correctionPET reconstructionOverall radiation doseCT acquisitionState-of-the-art deep learning methodsRadiation hazardRadiation doseCNN-based methodsState-of-the-artMedical image translationPatient studiesDiffusion modelDeep learning methodsHigh computation costHuman patient studiesClinical imaging toolImage translationBaseline methodsMulti-viewCNN-basedMultiple viewsOutcomes of Reduced Elective Nodal Radiation Dose for Laryngeal, Hypopharyngeal and p16 Negative Oropharyngeal Cancers
Zakeri K, Shang T, Yu Y, Chen L, Shamseddine A, Kang J, Tsai C, Sherman E, Wong R, McBride S, Gelblum D, Riaz N, Lee N. Outcomes of Reduced Elective Nodal Radiation Dose for Laryngeal, Hypopharyngeal and p16 Negative Oropharyngeal Cancers. International Journal Of Radiation Oncology • Biology • Physics 2024, 120: e807. DOI: 10.1016/j.ijrobp.2024.07.1772.Peer-Reviewed Original ResearchP16-negative oropharyngeal squamous cell carcinomaNegative oropharyngeal squamous cell carcinomasOropharyngeal squamous cell carcinomaDistant recurrenceSquamous cell carcinomaNodal recurrenceRadiotherapy doseLocoregional recurrenceP16 statusCell carcinomaHypopharynx cancerP16-negative oropharyngeal cancerHead and neck cancer patientsRadiation doseElective nodal volumesP16-negative diseaseNode-positive diseaseDecrease treatment toxicityNeck cancer patientsPrimary outcome measureConcurrent cetuximabConcurrent chemotherapyLocoregional controlMedian followNodal diseaseBiology of Exfoliation of Plasma Membrane-Derived Vesicles and the Radiation Response: Historical Background, Applications in Biodosimetry and Cell-Free Therapeutics, and Quantal Mechanisms for Their Release and Function with Implications for Space Travel
Dainiak N. Biology of Exfoliation of Plasma Membrane-Derived Vesicles and the Radiation Response: Historical Background, Applications in Biodosimetry and Cell-Free Therapeutics, and Quantal Mechanisms for Their Release and Function with Implications for Space Travel. Radiation Research 2024, 202: 328-354. PMID: 38981604, DOI: 10.1667/rade-24-00078.1.Peer-Reviewed Original ResearchCell-free therapeuticsPlasma membrane-derived vesiclesExtracellular vesiclesExposure to ionizing radiationIndividual radiation dosesMembrane-derived vesiclesExposure to radiationProperties of extracellular vesiclesPathogenesis of diseaseSpace travelDeep spaceRadiation doseInhibitory moleculesSignal traffickingHuman cellsClinical disordersQuantal mechanismRadiation responseMembrane turnoverVesiclesNucleic acidsVesicle surfaceBiophysical propertiesCell-freeRadiationNext-generation digital chest tomosynthesis
Gange C, Ku J, Gosangi B, Liu J, Maolinbay M. Next-generation digital chest tomosynthesis. Journal Of Clinical Imaging Science 2024, 14: 22. PMID: 38975057, PMCID: PMC11225395, DOI: 10.25259/jcis_4_2024.Peer-Reviewed Original ResearchRadiation doseLow dose chest CTLung phantomLung nodulesEffective radiation dosePlane resolutionLow radiation doseLow dose CTPhantomSimulated pulmonary nodulesChest CTChest radiologistsHealthy volunteersPulmonary nodulesDose CTAnatomical locationNodule detectionImaging characteristicsTomosynthesisNodulesLungDoseDetect lung nodulesDevicesPotential utilityMulticenter Quantification of Radiation Exposure and Associated Risks for Prostatic Artery Embolization in 1476 Patients.
Ayyagari R, Rahman S, Grizzard K, Mustafa A, Staib L, Makkia R, Bhatia S, Bilhim T, Carnevale F, Davis C, Fischman A, Isaacson A, McClure T, McWilliams J, Nutting C, Richardson A, Salem R, Sapoval M, Yu H. Multicenter Quantification of Radiation Exposure and Associated Risks for Prostatic Artery Embolization in 1476 Patients. Radiology 2024, 310: e231877. PMID: 38441098, DOI: 10.1148/radiol.231877.Peer-Reviewed Original ResearchConceptsProstatic artery embolizationCumulative air kermaRadiation-related adverse eventsBody mass indexAdverse eventsEffective doseFluoroscopy timeArtery embolizationRadiation doseKerma area product valuesMedian cumulative air kermaMedian effective radiation doseFluoroscopy unitPatient body mass indexRadiation exposureTwo-sample <i>t</i> test wasRadiation dose dataBenign prostatic hyperplasiaFluoroscopy-guided proceduresPatient radiation exposureEffective radiation doseRadiation field areaRadiation effective doseWilcoxon rank sum testInvasive angiographic procedures
2023
In Vivo Verification of Electron Paramagnetic Resonance Biodosimetry Using Patients Undergoing Radiation Therapy Treatment
Draeger E, Roberts K, Decker R, Bahar N, Wilson L, Contessa J, Husain Z, Williams B, Flood A, Swartz H, Carlson D. In Vivo Verification of Electron Paramagnetic Resonance Biodosimetry Using Patients Undergoing Radiation Therapy Treatment. International Journal Of Radiation Oncology • Biology • Physics 2023, 119: 292-301. PMID: 38072322, DOI: 10.1016/j.ijrobp.2023.11.029.Peer-Reviewed Original ResearchHealthy volunteersDose rangeTotal body irradiationTotal body irradiation treatmentSignificant correlationRadiation therapy patientsPatient ageBody irradiationImmediate triageTherapy patientsClinical conditionsParticipants' teethPatientsNeck patientsUnknown dosesDosePatient dataRadiotherapy treatmentRadiation doseTeethTreatmentVolunteersSubsequent fractionsLuminescent dosimetersRadiation responseHigh-Dose Targeted Radiation with 131I-Apamistamab Prior to HCT Demonstrated a Dose-Response for Durable Complete Remission in Patients with R/R AML
Litzow M, Chen G, Gyurkocza B, Nath R, Seropian S, Choe H, Abboud C, Koshy N, Tomlinson B, Abhyankar S, Foran J, Abedin S, Al-Kadhimi Z, Kebriaei P, Sabloff M, Orozco J, Jamieson K, Magalhaes-Silverman M, Van Besien K, Schuster M, Law A, Mayer S, Lazarus H, Leung E, Chen M, Natwa M, Spross J, Li K, Nagl N, Haeuber E, Vusirikala M, Nahar A, Sandmaier B, Pagel J, Giralt S, Desai A, Wahl R, Pandit-Taskar N, Brodin P, Stiff P. High-Dose Targeted Radiation with 131I-Apamistamab Prior to HCT Demonstrated a Dose-Response for Durable Complete Remission in Patients with R/R AML. Blood 2023, 142: 3529. DOI: 10.1182/blood-2023-189040.Peer-Reviewed Original ResearchDurable complete remissionConventional careLiver dosePrimary endpointBone marrowR AMLComplete remissionLiver ratioHigh doseLeukemic cellsRadiation doseAllogeneic hematopoietic cell transplantRadiation dose-response relationshipHematopoietic cell transplantMost older patientsPhase 3 studyTotal body irradiationFavorable biodistributionRadiation dose toleranceYears of ageDose toleranceDose-response relationshipDiseased bone marrowMedian doseRefractory AMLConcurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer
Han J, Zakeri K, Raab G, Hesse J, Shamseddine A, Chen L, Yu Y, Kang J, McBride S, Riaz N, Tsai C, Gelblum D, Sherman E, Wong R, Michel L, Lee N. Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer. Head & Neck 2023, 45: 2207-2216. PMID: 37439286, PMCID: PMC10981461, DOI: 10.1002/hed.27456.Peer-Reviewed Original ResearchConceptsLocoregional recurrenceDistant metastasisOverall survivalHNSCC patientsConcurrent carboplatinDefinitive chemoradiationConsecutive HNSCC patientsDefinitive radiation therapyMedian radiation doseKaplan-Meier methodCumulative incidence functionFree survivalAdvanced headMedian ageMedian dosesNeck cancerAUC 1Radiation therapyCarboplatinPatientsChemoradiationPaclitaxelRadiation doseExcellent optionIncidence functionCyberKnife Stereotactic Radiosurgery for Growing Vestibular Schwannoma: Longitudinal Tumor Control, Hearing Outcomes, and Predicting Post‐Treatment Hearing Status
Hildrew D, Perez P, Mady L, Li J, Nilsen M, Hirsch B. CyberKnife Stereotactic Radiosurgery for Growing Vestibular Schwannoma: Longitudinal Tumor Control, Hearing Outcomes, and Predicting Post‐Treatment Hearing Status. The Laryngoscope 2023, 134: s1-s12. PMID: 37178050, DOI: 10.1002/lary.30731.Peer-Reviewed Original ResearchConceptsTumor control rateCyberKnife stereotactic radiosurgeryHearing outcomesVestibular schwannomaControl rateStereotactic radiosurgeryRetrospective case series reviewCase series reviewThird of patientsProportional hazard modelingMaximum radiation doseSeries reviewTumor controlAvailable audiogramsOtolaryngology-HeadTumor volumeEffective treatmentClass APatientsHearing statusAmerican AcademyHazard modelingVolumetric analysisRadiation doseOutcomes
2022
Utilization and Outcomes of Radiation in Stage IV Esophageal Cancer
Zhan P, Canavan M, Ermer T, Pichert M, Li A, Maduka R, Kaminski M, Johung K, Boffa D. Utilization and Outcomes of Radiation in Stage IV Esophageal Cancer. JTO Clinical And Research Reports 2022, 3: 100429. PMID: 36483656, PMCID: PMC9722471, DOI: 10.1016/j.jtocrr.2022.100429.Peer-Reviewed Original ResearchStage IV esophageal cancerNational Cancer DatabaseEsophageal cancerCancer DatabaseRadiation doseSurvival advantageMedian total radiation dosePropensity score-matched pairsOutcome of radiationRetrospective cohort studyKaplan-Meier analysisTotal radiation doseAppropriate radiation dosePalliative regimensCohort studyMedian ageRadiation administrationSurvival associationsBetter survivalPatientsLocal controlCancerDosePalliationFurther studiesPHSOR05 Presentation Time: 12:50 PM The Effect of Quantum Noise on a Novel Multilateration-Based Brachytherapy Source Localization Approach
Jensen P, Tien C, Chen Z. PHSOR05 Presentation Time: 12:50 PM The Effect of Quantum Noise on a Novel Multilateration-Based Brachytherapy Source Localization Approach. Brachytherapy 2022, 21: s25-s26. DOI: 10.1016/j.brachy.2022.09.023.Peer-Reviewed Original ResearchQuantum noiseSource positionAcquisition timePixel sizePhoton-counting systemParticle detectorsImage fluxesLarge pixel sizeDominant sourceAchievable resolutionPhysics principlesSource strengthAxis displacementCamera systemPoint sourcesParameter rangeSingle camera systemSecond cameraDose reconstructionSystem setupRadiation doseCentral axisDual-camera systemPhotonsSetup
2021
Determining the Minimal Required Ultra-Low-Dose CT Dose Level for Reliable Attenuation Correction of 18F-FDG PET/CT: A Phantom Study
Cheng D, Ghita M, Menard D, Chen MK. Determining the Minimal Required Ultra-Low-Dose CT Dose Level for Reliable Attenuation Correction of 18F-FDG PET/CT: A Phantom Study. Journal Of Nuclear Medicine Technology 2021, 50: 126-131. PMID: 34750234, DOI: 10.2967/jnmt.121.262943.Peer-Reviewed Original ResearchReliable attenuation correctionUltra-low dose CTPrecise attenuation correctionAttenuation correctionImaging Performance AssessmentRadiation doseSingle bed positionBeam collimationS rotationTube rotation timeCT acquisition techniquesAssociated radiation doseDose CT protocolF-FDG PET-CT studiesCT radiation dosePhantom studyRadiation dose reductionTube voltageCT dosePET imagesTube currentHelical pitchUltra-low doseKVpPET acquisitionThe Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity
Lo A, Liu A, Liu Q, Yasui Y, Castellino S, Kelly K, Herrera A, Friedberg J, Friedman D, Schwartz C, Bergeron-Gravel S, Dama H, Roberts K, Constine L, Hodgson D. The Evolution of Children's Oncology Group Hodgkin Lymphoma Trials: Predicted Impact on Late Cardiac Toxicity. Blood 2021, 138: 881. DOI: 10.1182/blood-2021-147678.Peer-Reviewed Original ResearchInvolved site radiotherapyCardiac radiation doseInvolved-field radiotherapyChildhood Cancer Survivor StudyPositron emission tomographyMediastinal radiotherapyChildren's Oncology GroupDoxorubicin doseCumulative incidenceCardiac toxicityCardiac diseaseRT useCardiac riskCardiac disease riskBulk diseaseOncology GroupLymphoma trialsTrial protocolRadiation doseLong-term cardiac riskDisease riskCumulative doxorubicin doseImpact of nivolumabLate cardiac toxicityMean heart doseAssociation of Heart and Lung Radiation Dose With COVID-Related Mortality
Talcott W, Peters G, Yu J, Park H. Association of Heart and Lung Radiation Dose With COVID-Related Mortality. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e424-e425. PMCID: PMC8536215, DOI: 10.1016/j.ijrobp.2021.07.1212.Peer-Reviewed Original ResearchLung radiation doseCOVID-19 infectionCOVID-related mortalityStudy cohortRadiation therapyOdds ratioRadiation dosePoor COVID-19 outcomesCOVID-19 positive patientsDosimetric parametersNon-metastatic patientsMultivariable logistic regressionConfidence intervalsNormal lung tissuesCOVID-19 outcomesLung radiation therapyCOVID-19MATERIAL/METHODSPrior radiation doseCardiovascular sequelaeEvaluable patientsHeart dosesHeart V5Lung V5Association of heartDiagnostic safety of a machine learning-based automatic patient selection algorithm for stress-only myocardial perfusion SPECT
Eisenberg E, Miller RJH, Hu LH, Rios R, Betancur J, Azadani P, Han D, Sharir T, Einstein AJ, Bokhari S, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Liang JX, Otaki Y, Tamarappoo BK, Dey D, Berman DS, Slomka PJ. Diagnostic safety of a machine learning-based automatic patient selection algorithm for stress-only myocardial perfusion SPECT. Journal Of Nuclear Cardiology 2021, 29: 2295-2307. PMID: 34228341, PMCID: PMC9020793, DOI: 10.1007/s12350-021-02698-4.Peer-Reviewed Original ResearchConceptsObstructive coronary artery diseaseCoronary artery diseaseHigh-risk coronary artery diseaseMyocardial perfusion imagingPatient selection algorithmTriple-vessel coronary artery diseasePrediction of CADML thresholdsStress-first protocolInvasive coronary angiographyReceiver operator characteristic curveOperator characteristic curveMyocardial perfusion SPECTArtery diseaseCoronary angiographyAnterior descendingClinical variablesClinical algorithmReader diagnosisRest imagingPerfusion SPECTPerfusion imagingDiagnostic safetyRadiation doseCharacteristic curveOptimal Radiation Dose for Stage III Lung Cancer—Should “Definitive” Radiation Doses Be Used in the Preoperative Setting?
Saffarzadeh AG, Canavan M, Resio BJ, Walters SL, Flores KM, Decker RH, Boffa DJ. Optimal Radiation Dose for Stage III Lung Cancer—Should “Definitive” Radiation Doses Be Used in the Preoperative Setting? JTO Clinical And Research Reports 2021, 2: 100201. PMID: 34590044, PMCID: PMC8474436, DOI: 10.1016/j.jtocrr.2021.100201.Peer-Reviewed Original ResearchLong-term mortality riskStage III NSCLCLow dosePreoperative settingMortality riskHigh doseRadiation doseClinical stage III patientsNational Cancer Database dataStage III lung cancerStage III patientsUse of surgeryLength of stayGy of radiationCox proportional hazardsComparative effectiveness analysisOptimal radiation doseSingle-dose strategyLong-term survivalRadiation dosesLogistic regression modelsDefinitive chemoradiotherapyN2 patientsNonsurgical patientsPerioperative outcomes
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply